Zweig-DiMenna Associates’s Pfizer PFE Stock Holding History

Zweig-DiMenna Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-321,849	Closed	-$11.2M	–	165
2020 Q3	$11.2M	Buy	+321,849	New	+$11.3M	0.76%	50
2015 Q4	–	Sell	-32,411	Closed	-$966K	–	286
2015 Q3	$966K	Buy	32,411 +24,190	+294%	+$776K	0.04%	139
2015 Q2	$262K	Sell	8,221 -7,800	-49%	-$254K	0.01%	171
2015 Q1	$529K	Buy	+16,021	New	+$509K	0.02%	155
2014 Q4	–	Sell	-9,486	Closed	-$266K	–	312
2014 Q3	$266K	Hold	9,486	–	–	0.01%	171
2014 Q2	$267K	Buy	+9,486	New	+$270K	0.01%	191

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Zweig-DiMenna Associates's PFE Position: Q4 2020 in Review

Zweig-DiMenna Associates sold out of Pfizer (PFE) in Q4 2020, closing a stake of 321,849 shares — an estimated $11.2M sold.

Zweig-DiMenna Associates first reported a position in PFE in Q2 2014 and held it in 6 quarters. The position peaked at $11.2M in Q3 2020. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Zweig-DiMenna Associates reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
Zweig-DiMenna Associates sold 321,849 Pfizer shares in Q4 2020, an estimated $11.2M.
Zweig-DiMenna Associates first reported a position in Pfizer in Q2 2014 and held it in 6 quarters.
Zweig-DiMenna Associates's Pfizer position peaked at $11.2M in Q3 2020.
2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2020, filed 26 Jan 2021.